Context
The International Vaccine Institute (IVI) announced that it has commenced a technology transfer of simplified oral cholera vaccine (OCV-S) to Hyderabad-based pharma major Biological E.
IVI Commences Tech Transfer of Oral Cholera Vaccine to Biological E
- Signing of Technology Licence Agreement: Biological E had signed a technology license agreement with IVI in 2023
- OCV-S: It is a simplified formulation of oral cholera vaccine with the potential to lower production costs while increasing production capacity for current and aspiring manufacturers.
About Cholera
- Bacterial Infection: It is a bacterial infection of the small intestine that causes a lot of watery diarrhea.
- Causing Agent: Vibrio cholerae
- Transmission: Cholera bacteria can be transmitted to people by contaminated water or food.
- Cholera can spread swiftly in areas where sewage and drinking water are not properly treated.
Prevention and Control of Cholera
- ORS Treatment: It is a disease that can be readily treated. The majority of patients can be successfully treated with immediate use of oral rehydration solution (ORS).
- Role of Zinc: Zinc is a crucial supplementary therapy for children under the age of five, and it also shortens the length of diarrhea.
- WHO-approved oral cholera vaccines (OCV): Dukoral, Shanchol, and Euvichol-Plus. All three vaccines require two doses to provide full protection.
Initiatives to Control Cholera
- World Health Organization’s Global Task Force on Cholera Control (GTFCC): It is a platform for technical exchange, coordination, and collaboration on cholera-related initiatives to increase the country’s capacity to prevent and control cholera
- Created in 1992 in response to an unprecedented cholera outbreak in Peru.
- Ending Cholera: A Roadmap for 2030 In 2017, the goal was to reduce cholera mortality by 90% and eliminate cholera in up to 20 countries by 2030.
- Country Support Platforms (CSP): To increase GTFCC support for countries, the International Federation of Red Cross and Red Crescent Societies (IFRC) offers multisectoral operational support.
Also Read: India’s First Indigenously Developed Hepatitis A Vaccine
To get PDF version, Please click on "Print PDF" button.